- Home
- KRRO vs LTRN Comparison
KRRO vs LTRN Comparison
Compare KRRO & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- LTRN
- Stock Information
- Founded
- KRRO 2014
- LTRN 2013
- Country
- KRRO United States
- LTRN United States
- Employees
- KRRO N/A
- LTRN N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- KRRO Health Care
- LTRN Health Care
- Exchange
- KRRO Nasdaq
- LTRN Nasdaq
- Market Cap
- KRRO 58.6M
- LTRN 49.9M
- IPO Year
- KRRO 2019
- LTRN 2020
- Fundamental
- Price
- KRRO $5.59
- LTRN $3.72
- Analyst Decision
- KRRO Buy
- LTRN Strong Buy
- Analyst Count
- KRRO 10
- LTRN 1
- Target Price
- KRRO $74.17
- LTRN $25.00
- AVG Volume (30 Days)
- KRRO 1.0M
- LTRN 72.4K
- Earning Date
- KRRO 11-12-2025
- LTRN 11-12-2025
- Dividend Yield
- KRRO N/A
- LTRN N/A
- EPS Growth
- KRRO N/A
- LTRN N/A
- EPS
- KRRO N/A
- LTRN N/A
- Revenue
- KRRO $7,371,000.00
- LTRN N/A
- Revenue This Year
- KRRO $116.91
- LTRN N/A
- Revenue Next Year
- KRRO N/A
- LTRN N/A
- P/E Ratio
- KRRO N/A
- LTRN N/A
- Revenue Growth
- KRRO N/A
- LTRN N/A
- 52 Week Low
- KRRO $5.42
- LTRN $2.55
- 52 Week High
- KRRO $56.69
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- KRRO 21.22
- LTRN 49.75
- Support Level
- KRRO $5.42
- LTRN $2.86
- Resistance Level
- KRRO $6.59
- LTRN $3.93
- Average True Range (ATR)
- KRRO 1.20
- LTRN 0.27
- MACD
- KRRO -0.82
- LTRN 0.06
- Stochastic Oscillator
- KRRO 0.70
- LTRN 70.09
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.